AstraZeneca, Pfizer begin accelerated review for COVID-19 vaccines in UK


The U.K. is expediting the approval process for the COVID-19 vaccines being developed by AstraZeneca and Pfizer, Newsy reported Nov. 1.

The country’s health regulator began an accelerated review for the COVID-19 vaccine candidate AstraZenec is developing with the University of Oxford. Regulators are conducting a “rolling review,” meaning they will examine clinical trial data in real time while planning with the drugmaker about manufacturing and distribution.

The U.K. is also speeding up the review process for Pfizer’s COVID-19 vaccine candidate, Bloomberg reported Oct. 31.

More articles on pharmacy:
Ascension launches pharmacy services business Ascension Rx
6 recent pharma industry exec moves
FDA lists essential medicines, countermeasures and pharmaceutical ingredients


© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.